AT305288B - Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone - Google Patents

Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone

Info

Publication number
AT305288B
AT305288B AT194271A AT194271A AT305288B AT 305288 B AT305288 B AT 305288B AT 194271 A AT194271 A AT 194271A AT 194271 A AT194271 A AT 194271A AT 305288 B AT305288 B AT 305288B
Authority
AT
Austria
Prior art keywords
pyrimidones
preparation
new
substituted tetrahydro
tetrahydro
Prior art date
Application number
AT194271A
Other languages
German (de)
English (en)
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Application granted granted Critical
Publication of AT305288B publication Critical patent/AT305288B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Hydrogenated Pyridines (AREA)
AT194271A 1970-03-05 1971-03-05 Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone AT305288B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1698270A 1970-03-05 1970-03-05

Publications (1)

Publication Number Publication Date
AT305288B true AT305288B (de) 1973-02-26

Family

ID=21780073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT194271A AT305288B (de) 1970-03-05 1971-03-05 Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone

Country Status (14)

Country Link
US (1) US3681349A (OSRAM)
AT (1) AT305288B (OSRAM)
BE (1) BE763745A (OSRAM)
CH (1) CH555343A (OSRAM)
DE (1) DE2110445C3 (OSRAM)
DK (1) DK127427B (OSRAM)
ES (1) ES388780A1 (OSRAM)
FR (1) FR2085673B1 (OSRAM)
GB (1) GB1294626A (OSRAM)
IL (1) IL36189A0 (OSRAM)
NL (1) NL7102519A (OSRAM)
NO (1) NO130728C (OSRAM)
SE (1) SE376420B (OSRAM)
ZA (1) ZA71928B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39003A (en) * 1971-03-25 1975-02-10 Morton Norwich Products Inc 1-(substituted benzyl)tetrahydro-2-(1h)-pyrimidones and their preparation
US3957785A (en) * 1971-12-02 1976-05-18 Societa' Farmaceutici Italia S.P.A. Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
US3956325A (en) * 1974-01-21 1976-05-11 Smithkline Corporation 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H) pyrimidinone
US4003900A (en) * 1976-03-11 1977-01-18 Morton-Norwich Products, Inc. 1-Benzyl-5-chloro-2-(1H)-pyrimidone
US4002627A (en) * 1976-03-26 1977-01-11 Morton-Norwich Products, Inc. 1-Benzyl-3-methyl-3,4,5,6-tetrahydro-2(1H) pyrimidone
US4052399A (en) * 1976-09-13 1977-10-04 Morton-Norwich Products, Inc. 1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride
US4052400A (en) * 1976-10-29 1977-10-04 Morton-Norwich Products, Inc. Hypertensive 1-substituted 2(1h)-pyrimidones
JP5486928B2 (ja) * 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックウレアおよびカルバメートインヒビター
ES2395081T3 (es) * 2007-07-26 2013-02-08 Vitae Pharmaceuticals, Inc. Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2252598A2 (en) * 2008-02-11 2010-11-24 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2715290A1 (en) * 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja) * 2008-03-18 2014-07-02 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
CA2723034A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8242111B2 (en) * 2008-05-01 2012-08-14 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
ES2421537T3 (es) * 2008-05-01 2013-09-03 Vitae Pharmaceuticals Inc Inhibidores cíclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
AR071236A1 (es) * 2008-05-01 2010-06-02 Vitae Pharmaceuticals Inc Inhibidores ciclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
CN104327062A (zh) * 2008-07-25 2015-02-04 贝林格尔·英格海姆国际有限公司 11β-羟基类固醇脱氢酶1的环状抑制剂
JP5390610B2 (ja) 2008-07-25 2014-01-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤
CA2744946A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
GEP20156309B (en) * 2009-04-30 2015-07-10 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5656986B2 (ja) 2009-06-11 2015-01-21 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １，３−オキサジナン−２−オン構造に基づく１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8552212B2 (en) 2009-11-05 2013-10-08 Boehringer Ingelheim International Gmbh Chiral phosphorus ligands
UY33001A (es) 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
WO2011149822A1 (en) 2010-05-26 2011-12-01 Boehringer Ingelheim International Gmbh 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
JP2013540801A (ja) 2010-11-02 2013-11-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝異常の治療のための組合せ医薬
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE562987A (OSRAM) * 1956-12-05
DE1121617B (de) * 1959-05-26 1962-01-11 Huels Chemische Werke Ag Verfahren zur Herstellung von Tetrahydropyrimidin-2-onderivaten
DE1545601A1 (de) * 1965-07-22 1969-08-07 Basf Ag Verfahren zur Herstellung von Hexahydro-pyrimidinderivaten
DE1670368A1 (de) * 1966-07-16 1970-11-05 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung aralkylsubstituierter Lactame und Cyclischer Harnstoffe
DE1670241A1 (de) * 1967-07-01 1971-01-28 Basf Ag Verfahren zur Herstellung von 2-Oxohexahydropyrimidinen

Also Published As

Publication number Publication date
SE376420B (OSRAM) 1975-05-26
BE763745A (fr) 1971-09-03
NO130728B (OSRAM) 1974-10-21
CH555343A (de) 1974-10-31
NL7102519A (OSRAM) 1971-09-07
FR2085673A1 (OSRAM) 1971-12-31
DE2110445A1 (de) 1971-11-04
DE2110445C3 (de) 1975-05-28
ES388780A1 (es) 1975-03-01
NO130728C (OSRAM) 1975-01-29
FR2085673B1 (OSRAM) 1974-09-06
US3681349A (en) 1972-08-01
DE2110445B2 (de) 1974-10-10
ZA71928B (en) 1972-09-27
GB1294626A (en) 1972-11-01
IL36189A0 (en) 1971-04-28
DK127427B (da) 1973-11-05

Similar Documents

Publication Publication Date Title
AT305288B (de) Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone
CH531000A (de) Verfahren zur Herstellung neuer Benzocycloheptathiophene
CH530415A (de) Verfahren zur Herstellung von Pyrimidinderivaten
AT317229B (de) Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen
AT311351B (de) Verfahren zur Herstellung neuer 1-Isopropyl-4-phenyl-2(1H)-chinazolinone
AT306731B (de) Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone
DK130115B (da) Analogifremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinoner.
CH507959A (de) Verfahren zur Herstellung neuer Pyrimidin-Derivate
CH515911A (de) Verfahren zur Herstellung von 3,4-Dihydro-4-phenyl-2(1H)-chinazolinonen
CH555816A (de) Verfahren zur herstellung von acetamid-s-oxid-verbindungen.
AT306046B (de) Verfahren zur Herstellung von neuen semicyclischen Amidinen
AT330143B (de) Verfahren zur herstellung von 2-substituierten 4-hydroxy -2- cyclopenten -1- onen
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
CH533120A (de) Verfahren zur Herstellung von Pyrimidinderivaten
AT313901B (de) Verfahren zur Herstellung von neuen Tetrahydropyrimidinverbindungen
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
AT301562B (de) Verfahren zur Herstellung von neuen 2,6-Dimorpholino-8-alkanolamino-pyrimido[5,4-d]pyrimidinen
CH514596A (de) Verfahren zur Herstellung von 4-Phenylchinazolin-2(1H)-thionen
CH557371A (de) Verfahren zur herstellung von substituierten 5-hydroxyoenanthsaeurelactonen.
AT308714B (de) Verfahren zur Herstellung von Hydroxypivalaldehyd
AT308106B (de) Verfahren zur Herstellung neuer 2-(4-Oxo-4H-1-benzopyran-7-yl)-oxy-isobuttersäure-Derivate
CH557793A (de) Verfahren zur herstellung von sebacinsaeurediestern.
AT316148B (de) Verfahren zur Herstellung von löslichen Kondensationsprodukten
CH514603A (de) Verfahren zur Herstellung neuer 4-Phenyl-2(1H)-chinazolinone
AT326665B (de) Verfahren zur herstellung von 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidin